Once again last week the market was hitting all-time highs, and once again insiders were selling shares at a furious pace. Who can blame them?
Boston Scientific reported its third-quarter financial results before the markets opened on Wednesday.
Chris Lange If the independent research firm Argus is correct, then Boston Scientific shareholders could see an upside of roughly 40% from the current price level.
Chris Lange The top analyst upgrades, downgrades and initiations seen on Thursday morning include Boston Scientific, Micron Technology, Salesforce.com, TransCanada and Walgreens Boots Alliance.
When Boston Scientific reported second-quarter results Wednesday, revenues were up 10% overall, with medical and surgical product sales up nearly 30%.
Paul Ausick The top analyst upgrades, downgrades and initiations seen on Monday morning include Alcoa, Boston Scientific, Schlumberger, Sony and Staples.
Merrill Lynch has some ideas about how to take advantage of the trends in health care going forward.
Despite the market rally, insiders are still buying at big levels, while insider selling remains dormant. This is a very positive sign for equity investors and the market as a whole.
While the natural inclination is to think that corporate executives would like to sell stock into a big market rally like the one this past week, the data sure didn’t confirm that.
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
Boston Scientific reported better-than-expected third-quarter financial results before the markets opened on Wednesday.
Chris Lange Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.
Thursday's top analyst upgrades, downgrades and initiations include Amazon.com, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie & Fitch.
The sell-off was long overdue, and it may prove to be the pause that refreshes. One thing is for sure, executives and 10% owners were out in full force buying this past…
Boston Scientific shares are up almost 50% in the past six months, and the stock has more than doubled from two years ago. The question is whether this turnaround can keep turning…
